Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection. 1997

A Tsubota, and H Kumada, and K Chayama, and Y Arase, and S Saitoh, and I Koida, and Y Suzuki, and M Kobayashi, and N Murashima, and K Ikeda
Department of Gastroenterology, Toranomon Hospital, Minato-ku, Tokyo, Japan.

OBJECTIVE Although biochemical and virological responses to interferon-alpha therapy for chronic hepatitis C virus infection have been extensively studied, long-term changes in liver histology have not been well documented. METHODS We retrospectively analyzed 105 paired liver biopsy specimens taken before and after treatment from 93 patients who persistently showed biochemical remission and an absence of viremia for up to 68 months. RESULTS The grading scores for necroinflammatory and fibrotic activity in the liver biopsy specimens decreased significantly after interferon-alpha therapy. Histological scores graded according to Knodell's components improved significantly in every category after interferon-alpha therapy. However, inflammatory cell infiltrates remained within the portal tracts for long periods; necroinflammation in the periportal and lobular regions were absent in most of the post-therapy specimens. The cumulative disappearance rate, calculated using the Kaplan-Meier method, was significantly lower for portal inflammation than for periportal or lobular necroinflammation but was equivalent to that for histological disease activity. On univariate analysis, age and fibrosis at the onset of treatment were significant factors influencing the response of histological disease activity to interferon-alpha therapy (p=0.025 and 0.049, respectively). Using Cox's proportional hazard analysis, age was the only significant independent predictor of histological response to treatment (p=0.035). CONCLUSIONS Clinical remission of chronic hepatitis C virus infection is associated with histological resolution of necroinflammation in the periportal and lobular regions. Host-related factors are likely to influence whether early remission of inflammation after interferon-alpha therapy occurs.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Tsubota, and H Kumada, and K Chayama, and Y Arase, and S Saitoh, and I Koida, and Y Suzuki, and M Kobayashi, and N Murashima, and K Ikeda
May 1996, Hepatology (Baltimore, Md.),
A Tsubota, and H Kumada, and K Chayama, and Y Arase, and S Saitoh, and I Koida, and Y Suzuki, and M Kobayashi, and N Murashima, and K Ikeda
March 2001, Clinical nephrology,
A Tsubota, and H Kumada, and K Chayama, and Y Arase, and S Saitoh, and I Koida, and Y Suzuki, and M Kobayashi, and N Murashima, and K Ikeda
January 2001, American journal of nephrology,
A Tsubota, and H Kumada, and K Chayama, and Y Arase, and S Saitoh, and I Koida, and Y Suzuki, and M Kobayashi, and N Murashima, and K Ikeda
January 2000, Journal of viral hepatitis,
A Tsubota, and H Kumada, and K Chayama, and Y Arase, and S Saitoh, and I Koida, and Y Suzuki, and M Kobayashi, and N Murashima, and K Ikeda
April 2001, Journal of gastroenterology,
A Tsubota, and H Kumada, and K Chayama, and Y Arase, and S Saitoh, and I Koida, and Y Suzuki, and M Kobayashi, and N Murashima, and K Ikeda
May 1996, Digestive diseases and sciences,
A Tsubota, and H Kumada, and K Chayama, and Y Arase, and S Saitoh, and I Koida, and Y Suzuki, and M Kobayashi, and N Murashima, and K Ikeda
May 1999, Journal of hepatology,
A Tsubota, and H Kumada, and K Chayama, and Y Arase, and S Saitoh, and I Koida, and Y Suzuki, and M Kobayashi, and N Murashima, and K Ikeda
February 1997, Italian journal of gastroenterology and hepatology,
A Tsubota, and H Kumada, and K Chayama, and Y Arase, and S Saitoh, and I Koida, and Y Suzuki, and M Kobayashi, and N Murashima, and K Ikeda
January 1997, The Journal of the Egyptian Public Health Association,
A Tsubota, and H Kumada, and K Chayama, and Y Arase, and S Saitoh, and I Koida, and Y Suzuki, and M Kobayashi, and N Murashima, and K Ikeda
January 2012, Terapevticheskii arkhiv,
Copied contents to your clipboard!